Acutus Medical, Inc. - Common Stock, par value $0.001 per share (AFIB)

CUSIP: 005111109

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 6 signals
Share change
+1,537,562
SEC-reported price per share
$28.81
Indexed holders
63
Value change
+$43,795,744
Number of buys
41
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
60,359,615

Security key

005111109

Report period

Q4 2020

Indexed institutions

63

Top holders

10

Ownership snapshot

Top reported holders of AFIB - Acutus Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2020
13F Highest disclosed value: $163,243,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $163.24M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $163.24M
DEERFIELD MANAGEMENT COMPANY, L.P. $129.39M
Capital World Investors $30.87M
Opaleye Management Inc. $22.35M
BlackRock Finance, Inc. $20.26M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$163,243,000
5,477,958 shares
— 30 Sep 2020
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$129,386,000
4,341,799 shares
— 30 Sep 2020
Capital World Investors
13F
Company
13F
—
denominator unverified
$30,871,000
1,035,935 shares
— 30 Sep 2020
Opaleye Management Inc.
13F
Company
13F
—
denominator unverified
$22,350,000
749,990 shares
— 30 Sep 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$20,263,000
679,986 shares
— 30 Sep 2020
AMERICAN FINANCIAL GROUP INC
13F
Company
13F
—
denominator unverified
$17,880,000
599,990 shares
— 30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
63
Shares
20,785,062
Indexed holders
63
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 indexed holders
68
Q4 2020 indexed holders
63
Indexed holder difference
-5
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .